43 results
8-K
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
therapeutic targets against cancers and other diseases. The resulting soluble, antibody-like cytokine/chemokine decoy receptors derived using the QTY … immunotherapy delivery, as well as broadening the range of therapeutic targets addressable by CAR T-cell therapies.
Item 9.01. Financial Statements
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
, greatly enhancing the solubility of designer peptides and proteins, therefore potentially expanding the repertoire of selected therapeutic targets … of the “cytokine storm” associated with COVID-19 and cellular immunotherapy delivery, as well as broadening the range of therapeutic targets addressable
PRE 14A
lgt05b
29 Aug 23
Preliminary proxy
4:55pm
424B3
vt1rqa9z19krkyu
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
6sdtompnjj72kl5 699z
8 Nov 22
Entry into a Material Definitive Agreement
9:15am
8-K
EX-99.1
xm7cved77al608j
2 May 22
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
c90 fez6wmo1lbpb
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am